Mantle cell lymphoma

Results: 65



#Item
21ASCO[removed]Clinical response by baseline characteristics in patients with relapsed and bortezomib-refractory multiple myeloma treated with panobinostat, bortezomib, and dexamethasone (PANORAMA 2) Melissa Alsina,1 Paul G.

ASCO[removed]Clinical response by baseline characteristics in patients with relapsed and bortezomib-refractory multiple myeloma treated with panobinostat, bortezomib, and dexamethasone (PANORAMA 2) Melissa Alsina,1 Paul G.

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2013-06-10 19:40:25
22Malignant Lymphoma, Guideline for Bone Marrow Staging Studies Bone marrow stagimg for known or suspected malignant lymphoma (ML) Testing begins with: ■ [removed]Pathology Consultation for lymph node evaluation ■ 70016

Malignant Lymphoma, Guideline for Bone Marrow Staging Studies Bone marrow stagimg for known or suspected malignant lymphoma (ML) Testing begins with: ■ [removed]Pathology Consultation for lymph node evaluation ■ 70016

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Language: English - Date: 2013-12-02 10:46:08
23Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHSCB/B04/P/a

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHSCB/B04/P/a

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2013-08-13 12:09:40
24National Cancer Drugs Fund List Ver3.1 Ver3.1  National CDF List

National Cancer Drugs Fund List Ver3.1 Ver3.1 National CDF List

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2015-01-22 16:13:36
25Microsoft Word - SC VELCADE Press Release - FINAL[removed]

Microsoft Word - SC VELCADE Press Release - FINAL[removed]

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2012-04-18 11:56:06
26Microsoft PowerPoint - DC Fontline Therapy Durie.ppt [Compatibility Mode]

Microsoft PowerPoint - DC Fontline Therapy Durie.ppt [Compatibility Mode]

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2012-04-18 11:53:08
27Cytogenetics Hematologic FISH Panel Patient Information Sheet - MC1235-134

Cytogenetics Hematologic FISH Panel Patient Information Sheet - MC1235-134

Add to Reading List

Source URL: www.mayomedicallaboratories.com

Language: English - Date: 2012-10-15 13:24:07
28 ASCO University Recommended Curriculum for Oncology Fellows Level 1 (Year 1) TUMOR TYPES Breast Level 1 Adjuvant Therapy in Older Women: ASCO Tumor Board 

 ASCO University Recommended Curriculum for Oncology Fellows Level 1 (Year 1) TUMOR TYPES Breast Level 1 Adjuvant Therapy in Older Women: ASCO Tumor Board 

Add to Reading List

Source URL: university.asco.org

Language: English - Date: 2014-12-30 16:16:44
29pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s

pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s

Add to Reading List

Source URL: www.pcodr.ca

Language: English - Date: 2015-01-09 16:28:10
30JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area  Product Name

JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area Product Name

Add to Reading List

Source URL: files.shareholder.com

Language: English